Clinuvel Pharmaceuticals Statistics
Total Valuation
CLVLY has a market cap or net worth of 383.05 million. The enterprise value is 223.91 million.
| Market Cap | 383.05M |
| Enterprise Value | 223.91M |
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | Sep 8, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.27% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 10.26% |
| Owned by Institutions (%) | 21.16% |
| Float | 41.72M |
Valuation Ratios
The trailing PE ratio is 16.15 and the forward PE ratio is 14.49.
| PE Ratio | 16.15 |
| Forward PE | 14.49 |
| PS Ratio | 6.15 |
| PB Ratio | 2.43 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 14.32 |
| P/OCF Ratio | 14.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.71, with an EV/FCF ratio of 8.37.
| EV / Earnings | 9.44 |
| EV / Sales | 3.31 |
| EV / EBITDA | 6.71 |
| EV / EBIT | 6.87 |
| EV / FCF | 8.37 |
Financial Position
The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.66 |
| Quick Ratio | 9.25 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 10.25 |
Financial Efficiency
Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 186.33%.
| Return on Equity (ROE) | 16.30% |
| Return on Assets (ROA) | 11.37% |
| Return on Invested Capital (ROIC) | 186.33% |
| Return on Capital Employed (ROCE) | 18.71% |
| Weighted Average Cost of Capital (WACC) | 9.32% |
| Revenue Per Employee | 3.89M |
| Profits Per Employee | 1.48M |
| Employee Count | 16 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, CLVLY has paid 10.08 million in taxes.
| Income Tax | 10.08M |
| Effective Tax Rate | 29.83% |
Stock Price Statistics
The stock price has increased by +7.08% in the last 52 weeks. The beta is 0.83, so CLVLY's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +7.08% |
| 50-Day Moving Average | 8.02 |
| 200-Day Moving Average | 7.53 |
| Relative Strength Index (RSI) | 51.84 |
| Average Volume (20 Days) | 2,044 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CLVLY had revenue of 62.29 million and earned 23.72 million in profits. Earnings per share was 0.47.
| Revenue | 62.29M |
| Gross Profit | 56.74M |
| Operating Income | 30.00M |
| Pretax Income | 33.80M |
| Net Income | 23.72M |
| EBITDA | 30.51M |
| EBIT | 30.00M |
| Earnings Per Share (EPS) | 0.47 |
Balance Sheet
The company has 146.93 million in cash and 346,508 in debt, with a net cash position of 146.58 million.
| Cash & Cash Equivalents | 146.93M |
| Total Debt | 346,508 |
| Net Cash | 146.58M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 157.88M |
| Book Value Per Share | 3.15 |
| Working Capital | 154.57M |
Cash Flow
In the last 12 months, operating cash flow was 26.94 million and capital expenditures -195,743, giving a free cash flow of 26.75 million.
| Operating Cash Flow | 26.94M |
| Capital Expenditures | -195,743 |
| Free Cash Flow | 26.75M |
| FCF Per Share | n/a |
Margins
Gross margin is 91.08%, with operating and profit margins of 48.16% and 38.07%.
| Gross Margin | 91.08% |
| Operating Margin | 48.16% |
| Pretax Margin | 54.26% |
| Profit Margin | 38.07% |
| EBITDA Margin | 48.98% |
| EBIT Margin | 48.16% |
| FCF Margin | 42.94% |
Dividends & Yields
This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.33%.
| Dividend Per Share | 0.03 |
| Dividend Yield | 0.33% |
| Dividend Growth (YoY) | -11.84% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.92% |
| Buyback Yield | 1.27% |
| Shareholder Yield | 1.60% |
| Earnings Yield | 6.19% |
| FCF Yield | 6.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CLVLY has an Altman Z-Score of 14.53 and a Piotroski F-Score of 5.
| Altman Z-Score | 14.53 |
| Piotroski F-Score | 5 |